PMID: 9443000Jan 27, 1998Paper

Premorbid adjustment and remission of positive symptoms in first-episode psychosis

European Child & Adolescent Psychiatry
G P AmmingerE Ernst

Abstract

The impact of premorbid social and intellectual functioning in childhood and early adolescence on the developmental course of schizophrenia is not sufficiently understood. In a retrospective case study (93 consecutive in-patients, 43 males and 50 females) of first-episode psychosis occurring in adolescence, the relationship between premorbid adjustment and short-term therapeutic outcome under treatment conditions was examined. All of the patients had a DSM-III-R diagnosis of schizophrenia (n = 56) or schizo-affective disorder (n = 37). The mean age of the patients at the time of the study was 15.8 (SD = 1.0). Premorbid functioning during childhood and early adolescence was assessed by using the Cannon-Spoor et al. Premorbid Adjustment Scale (PAS) and studied with respect to its prognostic relevance for short-term therapeutic outcome (eight weeks) under neuroleptic treatment (350-700 mg Chlorpromazin dose equivalent). Criteria for clinical outcome were obtained from the study by Pearlson et al. (1989) which defines three grades (complete remission, partial remission and no response), according to the degree of positive symptomatology. Statistical analysis was based on nonparametric variance analysis. Patients with complete remis...Continue Reading

References

Jan 1, 1992·Schizophrenia Bulletin·R M MurrayS W Lewis
Jan 1, 1992·Schizophrenia Bulletin·G L Haas, J A Sweeney
Nov 1, 1992·The American Journal of Psychiatry·V E Pollock
Jan 1, 1992·Schizophrenia Bulletin·A S David, L Appleby
Jan 1, 1992·Archives of General Psychiatry·T H McGlashan, W S Fenton
Nov 1, 1991·Archives of General Psychiatry·W S Fenton, T H McGlashan
May 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·J S WerryL Chard
Jun 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·A S BellackK T Mueser
Mar 1, 1990·The American Journal of Psychiatry·R W BuchananW T Carpenter
May 1, 1990·Journal of Abnormal Psychology·K T MueserJ H Wade
Jan 1, 1988·Schizophrenia Bulletin·J R Asarnow
Mar 1, 1982·The American Journal of Psychiatry·N C AndreasenM R Smith
Jan 1, 1982·Schizophrenia Bulletin·H E Cannon-SpoorR J Wyatt
Jan 1, 1994·Schizophrenia Bulletin·E F WalkerD Davis
Jun 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·G A Carlson
Jan 1, 1994·Schizophrenia Bulletin·J S WerryM Ham
Jan 1, 1994·Acta Psychiatrica Scandinavica. Supplementum·K H NuechterleinM F Green
May 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·D J CastleR M Murray
Nov 1, 1993·The American Journal of Psychiatry·E F WalkerA J Smith
Jan 1, 1993·Schizophrenia Bulletin·R H DworkinL Erlenmeyer-Kimling
Feb 1, 1994·The Journal of Nervous and Mental Disease·R H DworkinL Erlenmeyer-Kimling
Jan 1, 1993·Schizophrenia Bulletin·L Erlenmeyer-KimlingA West

❮ Previous
Next ❯

Citations

May 24, 2005·Schizophrenia Research·Robert A LasserJohn M Kane
Feb 6, 2004·Journal of Psychiatric Research·Alp UçokNurten Turan
Jun 6, 2002·Schizophrenia Research·Neil J PrestonDavid J Castle
May 27, 2003·Schizophrenia Research·Jean AddingtonDonald Addington
Feb 18, 2005·Psychopharmacology·Carmen Chung, Gary Remington
Apr 24, 2012·European Psychiatry : the Journal of the Association of European Psychiatrists·S LuutonenR K R Salokangas
Apr 20, 2010·Comprehensive Psychiatry·Deanna L KellyRobert R Conley
Mar 21, 2007·Schizophrenia Research·Christine SchmaelMarcella Rietschel
Dec 3, 2005·Child and Adolescent Psychiatric Clinics of North America·Harvey N KranzlerSanjiv Kumra
Feb 26, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Benedicto Crespo-FacorroJosé Luis Vázquez-Barquero
Dec 10, 2013·European Psychiatry : the Journal of the Association of European Psychiatrists·R K R SalokangasUNKNOWN EPOS group
Mar 13, 2016·Early Intervention in Psychiatry·Lisa N CruzMichelle Friedman-Yakoobian
Jun 15, 2005·Acta Psychiatrica Scandinavica·J Addington, D Addington
Sep 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·D WadeP D McGorry
Nov 22, 2000·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·N M Menezes, E Milovan
Oct 24, 2007·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Ashok MallaRobert B Zipursky
Dec 12, 2012·Harvard Review of Psychiatry·Bandar AlAqeel, Howard C Margolese
Jan 22, 2014·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Martin LepageChristopher R Bowie
Jul 10, 2018·Acta Psychiatrica Scandinavica·P BucciUNKNOWN Italian Network for Research on Psychoses
Apr 30, 2020·European Psychiatry : the Journal of the Association of European Psychiatrists·Alex HatzimanolisNicholas C Stefanis
Aug 3, 2007·International Review of Psychiatry·Marinos Kyriakopoulos, Sophia Frangou
Apr 20, 2004·The Journal of Nervous and Mental Disease·Joseph F Goldberg, Carrie L Ernst
Jan 1, 2015·NPJ Schizophrenia·Covadonga M Díaz-CanejaCelso Arango

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
M J CuestaJ de Leon
The British Journal of Psychiatry : the Journal of Mental Science
H KraussM Rietschel
© 2021 Meta ULC. All rights reserved